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The guideline on the use of fresh-frozen plasma (FFP), cryoprecipitate and 
cryosupernatant is currently under review. While the guideline is being reviewed, the 
BCSH Transfusion Task Force group would like to issue the following communication and 
recommendations:  
 
The recently published BCSH guideline “A practical guideline for the haematological 
management of major haemorrhage” (Hunt et al, 2015), recommends that transfusion 
laboratories seeing major haemorrhage cases due to trauma should consider having pre-
thawed plasma on standby to allow FFP to be immediately available for the management 
of major bleeding. Some centres are already doing this; however this practice is leading to 
practical difficulties, including FFP wastage due to the current shelf-life of pre-thawed FFP 
being only 24 hours.   
 
The Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services’ 
Professional Advisory Committee (JPAC) has reviewed the available data on FFP with the 
view to extending the shelf life of pre-thawed FFP to > 24 hours, and have agreed that:  
 
- the shelf life of thawed methylene blue-treated FFP should remain the same (i.e. 24 
hours) and not be extended 
- the shelf life of thawed standard FFP can be extended from 24 hours to 120 hours, 
to enable rapid provision of FFP for the management of unexpected major 
haemorrhage without excessive wastage 
(http://www.transfusionguidelines.org.uk/document-library/supporting-papers).  
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For the purposes of this addendum solvent detergent FFP (Octaplas) is not considered as 
this is a licensed medicinal product and therefore its shelf-life following thawing is 
governed by the manufacturer (Octapharma). 
 
 
Recommendations  
 
Once thawed, standard FFP may be stored at 4 ± 2°C in an approved temperature-
controlled blood storage refrigerator before administration to the patient as long as the 
infusion is completed within 24 hours of thawing, or within 120 hours of thawing only for 
patients who develop unexpected major bleeding (e.g. trauma) and for whom delay in 
providing FFP is detrimental.  
 
Pre-thawed FFP that is out of a controlled temperature environment (4 ±2°C), can be 
accepted back into temperature controlled storage if this occurs on one occasion only of 
less than 30 minutes. Transfusion of FFP should be completed within 4 hours of issue out 
of a controlled temperature environment.*  
 
Apart from clinical scenarios of unexpected major haemorrhage transfusion laboratories 
should use FFP that has been thawed for a maximum of 24 hours prior to clinical use due 
to the fact that clotting factor activity (particularly FV, FVII and FVIII) drops over time 
during storage at 4 ±2°C. 
 
 
In order to reduce the risk of bacterial contamination/growth the following mitigating factors 
must be followed for thawed FFP: 
o Protocols must be in place to ensure that the thawing equipment is cleaned daily 
and maintained to minimise the risk of bacterial contamination.  
o After thawing, and at the time of administration, the content should be inspected to 
ensure that no precipitate is visible and that the component packaging is intact.  
o Thawing methods that do not directly expose units to water must be used to 
minimise bacterial contamination when thawing FFP that will be stored for up to 120 
hours prior to clinical use. 
 
 
 
*At present there is a lack of evidence relating to how long thawed plasma can safely 
remain out of controlled temperature storage. The recommendation in this guideline is 
based on current practice in other countries and expert opinion, extrapolated from 
evidence on red cell storage with the aim of minimising FFP wastage while also ensuring 
safety of the component for recipients. The recommendation may change in the future as a 
result of research carried out on FFP storage and bacterial growth. 
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